Differential effects of nomifensine and imipramine on motivated behavior in the runway model of intracranial self-stimulation

Satoru Esumi, Yoichi Kawasaki, Akihiko Nakamoto, Hidenori Sagara, Yutaka Gomita, Yoshihisa Kitamura, Toshiaki Sendo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A motivational deficit (the loss of pleasure or interest in previously rewarding stimuli) is one of the core symptoms of major depression, and valid models evaluating the motivational effects of drugs are needed. It was recently demonstrated that the priming stimulation effect in the runway model of intracranial self-stimulation (ICSS) can be used as a model system to study the motivational effects of drugs. However, the characteristics of this novel experimental model have not been fully clarified. In this study, we investigated the effects of nomifensine and imipramine in the runway ICSS model, forced swim tests, and locomotor activity tests to differentiate motivation from affective-like states. Nomifensine dose-dependently increased running speed on the runway and decreased immobility time in the forced swim test. In contrast, imipramine decreased running speed on the runway although it also decreased immobility time in the forced swim test. In addition, the motivation-enhancing effect of nomifensine in the runway model was completely inhibited by pretreatment with the dopamine receptor antagonist haloperidol, although nomifensine-induced increases in locomotion were not affected by haloperidol. These results demonstrate that nomifensine displays motivation-enhancing and antidepressant-like effects. In addition, the motivational effects of nomifensine in the runway ICSS model are primarily mediated by dopamine receptors and enhancements of motivated behavior do not simply reflect hyperlocomotion.

Original languageEnglish
Pages (from-to)186-191
Number of pages6
JournalEuropean Journal of Pharmacology
Volume720
Issue number1-3
DOIs
Publication statusPublished - Nov 15 2013

Fingerprint

Nomifensine
Self Stimulation
Imipramine
Motivation
Haloperidol
Locomotion
Running
Pleasure
Dopamine Antagonists
Dopamine Receptors
Pharmaceutical Preparations
Antidepressive Agents
Theoretical Models
Depression

Keywords

  • Forced swimming test
  • Haloperidol
  • Intracranial self-stimulation
  • Locomotor activity
  • Motivation
  • Nomifensine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Differential effects of nomifensine and imipramine on motivated behavior in the runway model of intracranial self-stimulation. / Esumi, Satoru; Kawasaki, Yoichi; Nakamoto, Akihiko; Sagara, Hidenori; Gomita, Yutaka; Kitamura, Yoshihisa; Sendo, Toshiaki.

In: European Journal of Pharmacology, Vol. 720, No. 1-3, 15.11.2013, p. 186-191.

Research output: Contribution to journalArticle

Esumi, Satoru ; Kawasaki, Yoichi ; Nakamoto, Akihiko ; Sagara, Hidenori ; Gomita, Yutaka ; Kitamura, Yoshihisa ; Sendo, Toshiaki. / Differential effects of nomifensine and imipramine on motivated behavior in the runway model of intracranial self-stimulation. In: European Journal of Pharmacology. 2013 ; Vol. 720, No. 1-3. pp. 186-191.
@article{b63843850f184d4db6d558bb21fa0a2d,
title = "Differential effects of nomifensine and imipramine on motivated behavior in the runway model of intracranial self-stimulation",
abstract = "A motivational deficit (the loss of pleasure or interest in previously rewarding stimuli) is one of the core symptoms of major depression, and valid models evaluating the motivational effects of drugs are needed. It was recently demonstrated that the priming stimulation effect in the runway model of intracranial self-stimulation (ICSS) can be used as a model system to study the motivational effects of drugs. However, the characteristics of this novel experimental model have not been fully clarified. In this study, we investigated the effects of nomifensine and imipramine in the runway ICSS model, forced swim tests, and locomotor activity tests to differentiate motivation from affective-like states. Nomifensine dose-dependently increased running speed on the runway and decreased immobility time in the forced swim test. In contrast, imipramine decreased running speed on the runway although it also decreased immobility time in the forced swim test. In addition, the motivation-enhancing effect of nomifensine in the runway model was completely inhibited by pretreatment with the dopamine receptor antagonist haloperidol, although nomifensine-induced increases in locomotion were not affected by haloperidol. These results demonstrate that nomifensine displays motivation-enhancing and antidepressant-like effects. In addition, the motivational effects of nomifensine in the runway ICSS model are primarily mediated by dopamine receptors and enhancements of motivated behavior do not simply reflect hyperlocomotion.",
keywords = "Forced swimming test, Haloperidol, Intracranial self-stimulation, Locomotor activity, Motivation, Nomifensine",
author = "Satoru Esumi and Yoichi Kawasaki and Akihiko Nakamoto and Hidenori Sagara and Yutaka Gomita and Yoshihisa Kitamura and Toshiaki Sendo",
year = "2013",
month = "11",
day = "15",
doi = "10.1016/j.ejphar.2013.09.079",
language = "English",
volume = "720",
pages = "186--191",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Differential effects of nomifensine and imipramine on motivated behavior in the runway model of intracranial self-stimulation

AU - Esumi, Satoru

AU - Kawasaki, Yoichi

AU - Nakamoto, Akihiko

AU - Sagara, Hidenori

AU - Gomita, Yutaka

AU - Kitamura, Yoshihisa

AU - Sendo, Toshiaki

PY - 2013/11/15

Y1 - 2013/11/15

N2 - A motivational deficit (the loss of pleasure or interest in previously rewarding stimuli) is one of the core symptoms of major depression, and valid models evaluating the motivational effects of drugs are needed. It was recently demonstrated that the priming stimulation effect in the runway model of intracranial self-stimulation (ICSS) can be used as a model system to study the motivational effects of drugs. However, the characteristics of this novel experimental model have not been fully clarified. In this study, we investigated the effects of nomifensine and imipramine in the runway ICSS model, forced swim tests, and locomotor activity tests to differentiate motivation from affective-like states. Nomifensine dose-dependently increased running speed on the runway and decreased immobility time in the forced swim test. In contrast, imipramine decreased running speed on the runway although it also decreased immobility time in the forced swim test. In addition, the motivation-enhancing effect of nomifensine in the runway model was completely inhibited by pretreatment with the dopamine receptor antagonist haloperidol, although nomifensine-induced increases in locomotion were not affected by haloperidol. These results demonstrate that nomifensine displays motivation-enhancing and antidepressant-like effects. In addition, the motivational effects of nomifensine in the runway ICSS model are primarily mediated by dopamine receptors and enhancements of motivated behavior do not simply reflect hyperlocomotion.

AB - A motivational deficit (the loss of pleasure or interest in previously rewarding stimuli) is one of the core symptoms of major depression, and valid models evaluating the motivational effects of drugs are needed. It was recently demonstrated that the priming stimulation effect in the runway model of intracranial self-stimulation (ICSS) can be used as a model system to study the motivational effects of drugs. However, the characteristics of this novel experimental model have not been fully clarified. In this study, we investigated the effects of nomifensine and imipramine in the runway ICSS model, forced swim tests, and locomotor activity tests to differentiate motivation from affective-like states. Nomifensine dose-dependently increased running speed on the runway and decreased immobility time in the forced swim test. In contrast, imipramine decreased running speed on the runway although it also decreased immobility time in the forced swim test. In addition, the motivation-enhancing effect of nomifensine in the runway model was completely inhibited by pretreatment with the dopamine receptor antagonist haloperidol, although nomifensine-induced increases in locomotion were not affected by haloperidol. These results demonstrate that nomifensine displays motivation-enhancing and antidepressant-like effects. In addition, the motivational effects of nomifensine in the runway ICSS model are primarily mediated by dopamine receptors and enhancements of motivated behavior do not simply reflect hyperlocomotion.

KW - Forced swimming test

KW - Haloperidol

KW - Intracranial self-stimulation

KW - Locomotor activity

KW - Motivation

KW - Nomifensine

UR - http://www.scopus.com/inward/record.url?scp=84890118940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890118940&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2013.09.079

DO - 10.1016/j.ejphar.2013.09.079

M3 - Article

VL - 720

SP - 186

EP - 191

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -